NR4A1 and breast carcinoma: While it is well known that ~15% of TNBCs are associated with BRCA1 mutations [13], the frequency of gBRCAMUT is up to 8% of all hormone receptor-positive breast cancers, and about 40% of breast cancers with low hormone receptor expression [139].